Innovation in COVID Testing Accurate Diagnostic Labs has demonstrated leadership in COVID-19 testing by launching FDA Emergency Use Authorized saliva-based tests and antibody assays, positioning itself as a key partner for healthcare providers seeking scalable, rapid testing solutions.

Strategic Partnerships Collaborations with Middlesex County, Rutgers University, RUCDR Infinite Biologics, and other local health authorities highlight opportunities to expand testing services and develop new diagnostic products in partnership with government and academic institutions.

Growing Market Presence With revenues ranging from 10M to 25M and significant media coverage related to COVID-19 initiatives, the company is positioned to expand its reach within the hospital and healthcare industry, serving as a reliable provider of innovative diagnostic testing.

Technological Capabilities Utilizing advanced tech stacks such as Nginx, WordPress, and Google APIs indicates a technologically capable organization, which can attract collaborations with other healthcare providers needing custom digital health solutions.

Market Opportunity Given the company's focus on rapid development of COVID diagnostics and antibody tests, there is a substantial opportunity for sales expansion into national health systems, laboratories, and organizations prioritizing large-scale infectious disease testing and management.